SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IPIC
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
1359 13 0 IPIC
Emcee:  David D. Long Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
434 Agree. I think the focus un Redux is what is driving the stock now, although Rcharles feicht-5/24/1997
433 This stock has not acted normally for over a year. Health care stocks are rotatScott Pratho-5/22/1997
432 The volume on the Sept Call options is going over 600 contracts on both the 20 Arthur S. Conroy-5/22/1997
431 WSJ: "Sales of Redux Hit a Plateau As Dieters and Insurers Balk" Mjlib-5/14/1997
430 Roche's new obesity drug could be seen two ways: It could validate the medScott Pratho-5/14/1997
429 Well maybe this well help explain the recent drop: competition is just around tP.Prazeres-5/13/1997
428 Having said that, I agree with you. I have been analyzing general chart patterPaul Dubsky-5/12/1997
427 I haven't responded in quite some time, but here I go. Something doesn'P.Prazeres-5/12/1997
426 I will watch for several days before I add my positions.Jeffers Hughes-5/12/1997
425 Looks good at the 15 level. I may take another position in this one again and Paul Dubsky-5/12/1997
424 The prescription rate will certainly pick up once the drug is descheduled. MoreScott Pratho-5/12/1997
423 This recent news must be why... The Wall Street Journal Monday highlighted INTKen Kuly-5/12/1997
422 What's the news today? Down $2 at the open??Paul Dubsky-5/12/1997
421 I agree that citicoline will be a monster drug! Probably >$500 mill (my predScott Pratho-5/12/1997
420 Dear Chas: Also the descheduling of Redux is a great news for shareholders. far east-5/11/1997
419 Here's my take on IPIC. The stock did a parabolic after Redux was introducecharles feicht-5/11/1997
418 Their pipeline of drugs is very impressive, especially the treatment for strokefar east-5/11/1997
417 Pretty quiet in the IPIC ranks these days. Nice to hear of all the positive thPat Shields-5/11/1997
416 Thanks for the comments. It's always great to hear from people who actuallPaul Dubsky-5/6/1997
415 I'm an ER Doctor and I'm new to this thread. I've read over the pasScott Pratho-5/6/1997
414 I hope that Ergo's lack of a corporate partner reflects that the company doJohn Bloxom-4/24/1997
413 I also like Ergo and have a much bigger position in it than IPIC. The fundamentJonathan Rothschild-4/23/1997
412 I would prefer not to mention the house (since I am a lawyer and therefore am sJohn Bloxom-4/23/1997
411 Oh well, looks like I missed a great buying opportunity at just under 13. Rallernie de la fuente-4/22/1997
410 CNBC essentially read the new release which came out last night and then mentioMCorbley-4/22/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News